The Patent Finder
US

Rescue Treatment of Post Operative Nausea and Vomiting

US 12,005,042 In force, term unresolved
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Apr 27, 2026 (Kroll Trustee Services Limited).

Term ends no later than Feb 9, 2038 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Held by Lxo Ireland Designated Activity Company; Lxo US, Inc. and Lxo US, Inc.
Filed May 17, 2022 as application 17/746,032 · Granted Jun 11, 2024
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Feb 9, 2018
Ends no later than
Feb 9, 2038
Granted
Jun 11, 2024
base term Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 9, 2018, when application PCT/GB2018/050374, the earliest non-provisional in its chain, was filed (this one was filed May 17, 2022)Feb 9, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Feb 9, 2038Medium confidence

This family

US 11,357,753In force
Feb 2038
Feb 2038
US 12,005,042this patent
no later than Feb 2038
no later than Feb 2038
US 12,329,740In force
Feb 2038
Feb 2038
Application 19/211,545Pending
not computed
not computed
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 17, 2022
Reel 59930, frame 921
Gilbert, Julian Clive; Gristwood, Robert William; Fox, GabrielAcacia Pharma Ltd.Assignment of Assignor's Interest
Oct 11, 2024
Reel 68873, frame 911
Acacia Pharma LimitedJpmorgan Chase Bank, N.a.Security Interest
Apr 1, 2025
Reel 70698, frame 351
JPMorgan Chase Bank, N.A., as Administrative AgentAcacia Pharma LimitedRelease of Security Interest
Mar 4, 2026
Reel 73967, frame 303
Acacia Pharma Limited; Acacia Pharma, Inc.; Eagle Pharmaceuticals, Inc.Lxo Ireland Designated Activity Company; Lxo US, Inc.Assignment of Assignor's Interest
Mar 4, 2026
reel/frame not recorded
Acacia Pharma Limited; Acacia Pharma, Inc.; Eagle Pharmaceuticals, Inc.Lxo Ireland Designated Activity CompanyAssignment of Assignor's Interest
Mar 4, 2026
reel/frame not recorded
Acacia Pharma Limited; Acacia Pharma, Inc.; Eagle Pharmaceuticals, Inc.Lxo US, Inc.Assignment of Assignor's Interest
Apr 27, 2026
Reel 74483, frame 163
Lxo Ireland Designated Activity CompanyKroll Trustee Services Limited, as Security AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited